2024 Here we go again., page-696

We recently hit 1.30, and you think BLA will only get us to 1.20? I get the logic of (1) market sees it as just another biotech, just another drug approval (2) market usually prices in anticipated approvals, but:

This is different. There is a sense of excitement out there about stem cells, and this will be the first allogeneic stem cell approval in the U.S. FDA will probably make an announcement about the approval stating how groundbreaking this is, and that will generate media excitement, which will drive buying. The market really isn't looking at this possibility. Post BLA the market will become aware of our pipeline which will help sustain the buying.

I will be very disappointed if BLA doesn't bring us to $2.

Don't forget that "the market" doesn't yet really include all the people who are totally unaware of our existence.